title: Recombinant human activated protein C for severe sepsis.
authors.forename: S
authors.initials: S
authors.lastname: Kapur
authors.forename: Y
authors.initials: Y
authors.lastname: Kupfer
authors.forename: S
authors.initials: S
authors.lastname: Tessler
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D011486:Protein C / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use*; D012306:Risk; D018746:Systemic Inflammatory Response Syndrome / Q000188:drug therapy*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D005343:Fibrinolytic Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated